NURS 613 advanced pharmacology EXAM A+ GRADE ASSURED COMPLETE SOLUTIONS AND VERIFIED ANSWERS LATEST UPDATE!!!!

PHARMACOLOGY EXAM zm




Exam Solution zm




Nurs 615 Pharm Exam 1 Maryville 2026 A+ GRADE ASS
zm zm zm zm zm zm zm zm zm




URED COMPLETE SOLUTIONS AND VERIFIED ANSWERS
zm zm zm zm zm z




(19859)
m




QUESTION 1 zm




How does hypoalbuminemia affect the process of prescribing?
zm zm zm zm zm zm zm




ANSWER

Low albumin = more free drug (bc the drug can't bind to albumin aka protein) = increased adverse
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm



effects



QUESTION 2 zm




What is a Black Box Warning:
zm zm zm zm zm




ANSWER

is considered a contraindication to administer that drug.
zm zm zm zm zm zm zm




QUESTION 3 zm




What is the drugs half-life?
zm zm zm zm




ANSWER

Half-
life specifically means the amount of time it takes for an administered drug to be halfway cleared fr
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm



om the system.
zm zm




QUESTION 4 zm




Peak of action: zm zm




ANSWER

,the time between drug administration and maximum concentration of drug in the blood stream. Best
zm zm zm zm zm zm zm zm zm zm zm zm zm zm



therapeutic effect.
zm zm




QUESTION 5 zm




Duration of action: zm zm




ANSWER

the time between onset of action and metabolism of drug below the minimum needed for an effect.
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm



The length of time you have the drug in your system.
zm zm zm zm zm zm zm zm zm zm




QUESTION 6 zm




According to the WHO what is the first step in the prescribing process?
zm zm zm zm zm zm zm zm zm zm zm zm




ANSWER

The first step is to define the patient's problem
zm zm zm zm zm zm zm zm




QUESTION 7 zm




The second step is to
zm zm zm zm




ANSWER

specify the therapeutic objective
zm zm zm




QUESTION 8 zm




The third step is to
zm zm zm zm




ANSWER

choose which drug or treatment is needed.
zm zm zm zm zm zm




QUESTION 9 zm




Step 4 of the WHO approach:
zm zm zm zm zm




ANSWER

Start the treatment
zm zm




QUESTION 10 zm




Step 5 of the WHO approach:
zm zm zm zm zm

, ANSWER

Educate the patient zm zm




QUESTION 11 zm




Step 6 of the WHO approach:
zm zm zm zm zm




ANSWER

Monitor the treatment zm zm




QUESTION 12 zm




Phase 1 of drug development:
zm zm zm zm




ANSWER

The drug is tested on healthy volunteers
zm zm zm zm zm zm




QUESTION 13 zm




Phase 2 of drug development:
zm zm zm zm




ANSWER

trials with people who have the disease for which the drug is thought to be effective
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm




QUESTION 14 zm




Phase 3 of drug development:
zm zm zm zm




ANSWER

Large numbers of patients in medical research centers receive the drug in phase 3. This larger samp
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm



ling provides information about infrequent or rare adverse effects. The FFA will approve a new drug
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm



application if phase 3 studies are satisfactory.
zm zm zm zm zm zm zm




QUESTION 15 zm




Phase 4 of drug development:
zm zm zm zm




ANSWER

This phase is voluntary and involves postmarket surveillance of the drug's therapeutic effects at the
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm



completion of phase 3. The pharmaceutical company receives reports from doctors and other health
zm zm zm zm zm zm zm zm zm zm zm zm zm zm



care professionals about the therapeutic results and adverse effects of the drug. Some medications, f
zm zm zm zm zm zm zm zm zm zm zm zm zm zm



or example, have been found to be toxic and have been removed from the market after their initial
zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm zm



release.